SCHEMBL4745902

SCHEMBL4745902

c1cnc2c(c1)-c1cccc3c1c-2cc1c2ccccc2c(-c2ccc4c(c2)-c2cccc5cccc-4c25)cc31

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
HSD17B10 Q99714 4/20 0.41
TSHR P16473 3/20 0.41
MAPK1 P28482 3/20 0.41
HPGD P15428 3/20 0.41
CASP1 P29466 3/20 0.41
HIF1A Q16665 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
CASP7 P55210 2/20 0.38
TP53 P04637 2/20 0.38
ATM Q13315 1/20 0.38
PTPRC P08575 2/20 0.34
CYP11B1 P15538 1/20 0.34
TOP2A P11388 1/20 0.34
MAOA P21397 1/20 0.33
CYP1A2 P05177 1/20 0.33
THRB P10828 1/20 0.33
TGFBR1 P36897 2/20 0.33
FEN1 P39748 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13320390 0.89 ALDH1A1 (0.45) ALDH1A1HSD17B10TSHRMAPK1HPGD
SCHEMBL4746252 0.88 ALDH1A1 (0.41) ALDH1A1HSD17B10TSHRMAPK1HPGD
SCHEMBL4745816 0.87 HTR2B (0.40) ALDH1A1HSD17B10TSHRMAPK1HPGD
SCHEMBL4746386 0.87 ALDH1A1 (0.38) ALDH1A1HSD17B10TSHRMAPK1HPGD
SCHEMBL4746287 0.87 PTPRC (0.39) ALDH1A1HSD17B10TSHRMAPK1HPGD
SCHEMBL4746241 0.86 ALDH1A1 (0.42) ALDH1A1HSD17B10TSHRMAPK1HPGD
SCHEMBL13320384 0.86 ALDH1A1 (0.45) ALDH1A1HSD17B10TSHRMAPK1HPGD
SCHEMBL4746384 0.86 ALDH1A1 (0.37) ALDH1A1HSD17B10TSHRMAPK1HPGD
SCHEMBL4746300 0.85 PTPRC (0.38) ALDH1A1HSD17B10TSHRMAPK1HPGD
SCHEMBL4746298 0.85 PTPRC (0.38) ALDH1A1HSD17B10TSHRMAPK1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173275-B2 Azaindenochrysene derivative and organic light-emitting device CANON KABUSHIKI KAISHA (JP) 2012-05-08 US disclosed
US-8173275-B2 Azaindenochrysene derivative and organic light-emitting device CANON KABUSHIKI KAISHA (JP) 2012-05-08 US disclosed
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2010-05-13 US disclosed
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2010-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE NR2E3, OR51E2, AZI2 ALDH1A1 179/4885HSD17B10 2132/4885TSHR 3386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.